FSWA
Financial Synergies Wealth Advisors Portfolio holdings
AUM
$918M
1-Year Return
13.84%
This Quarter Return
+8.68%
1 Year Return
+13.84%
3 Year Return
+48.65%
5 Year Return
+63.97%
10 Year Return
–
AUM
$646M
AUM Growth
+$64.3M
(+11%)
Cap. Flow
+$16.3M
Cap. Flow
% of AUM
2.53%
Top 10 Holdings %
Top 10 Hldgs %
69.29%
Holding
510
New
42
Increased
121
Reduced
64
Closed
49
Top Buys
Top Sells
| 1 |
Vanguard Extended Market ETF
VXF
|
$6.92M |
| 2 |
Vanguard Growth ETF
VUG
|
$6.39M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
$3.52M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
$2.58M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$1.05M |
Sector Composition
| 1 | Energy | 0.53% |
| 2 | Financials | 0.28% |
| 3 | Technology | 0.28% |
| 4 | Consumer Discretionary | 0.24% |
| 5 | Healthcare | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Organon & Co
OGN
$2.7B
| $1.48K | ﹤0.01% |
53
+33
| +165% | +$922 |
|
|
HZNP
277
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.48K | ﹤0.01% |
13
-11
| -46% | -$1.25K |
|
278
Dollar General
DG
$24.1B
| $1.48K | ﹤0.01% |
6
| – | – |
|
279
Sumitomo Mitsui Financial
SMFG
$105B
| $1.47K | ﹤0.01% |
+183
| New | +$1.47K |
|
280
Citigroup
C
$176B
| $1.45K | ﹤0.01% |
32
+4
| +14% | +$181 |
|
281
Mettler-Toledo International
MTD
$26.9B
| $1.45K | ﹤0.01% |
1
| – | – |
|
282
SAP
SAP
$313B
| $1.45K | ﹤0.01% |
+14
| New | +$1.45K |
|
283
Neurocrine Biosciences
NBIX
$14.3B
| $1.43K | ﹤0.01% |
12
| – | – |
|
284
TJX Companies
TJX
$155B
| $1.43K | ﹤0.01% |
18
-11
| -38% | -$876 |
|
285
Progressive
PGR
$143B
| $1.43K | ﹤0.01% |
11
| – | – |
|
286
Royalty Pharma
RPRX
$15.6B
| $1.42K | ﹤0.01% |
36
+16
| +80% | +$632 |
|
287
T-Mobile US
TMUS
$284B
| $1.4K | ﹤0.01% |
10
| – | – |
|
288
Lowe's Companies
LOW
$151B
| $1.4K | ﹤0.01% |
7
| – | – |
|
289
Viatris
VTRS
$12.2B
| $1.38K | ﹤0.01% |
124
| – | – |
|
290
Banco Bilbao Vizcaya Argentaria
BBVA
$105B
| $1.38K | ﹤0.01% |
+229
| New | +$1.38K |
|
291
Goldman Sachs
GS
$223B
| $1.37K | ﹤0.01% |
+4
| New | +$1.37K |
|
292
DexCom
DXCM
$31.6B
| $1.36K | ﹤0.01% |
+12
| New | +$1.36K |
|
293
Avantor
AVTR
$9.07B
| $1.35K | ﹤0.01% |
64
+1
| +2% | +$21 |
|
294
GoDaddy
GDDY
$20.1B
| $1.35K | ﹤0.01% |
18
| – | – |
|
295
Colgate-Palmolive
CL
$68.8B
| $1.34K | ﹤0.01% |
17
| – | – |
|
296
Exact Sciences
EXAS
$10.2B
| $1.34K | ﹤0.01% |
+27
| New | +$1.34K |
|
297
Arista Networks
ANET
$180B
| $1.34K | ﹤0.01% |
44
| – | – |
|
298
Trimble
TRMB
$19.2B
| $1.32K | ﹤0.01% |
+26
| New | +$1.32K |
|
299
Equinix
EQIX
$75.7B
| $1.31K | ﹤0.01% |
+2
| New | +$1.31K |
|
300
Synopsys
SNPS
$111B
| $1.28K | ﹤0.01% |
4
| – | – |
|